SCHEMBL2730721

SCHEMBL2730721

CCOC(=O)c1c(Cl)c2ccccc2n1-c1ccc(C=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.47
▸ GAA P10253 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.42
▸ ELANE P08246 3/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ BLM P54132 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730920 0.88 GAA (0.44) RECQLALDH1A1GAAMAPTMEN1
SCHEMBL2731177 0.87 MAPK8 (0.44) ALDH1A1GAAMAPTKMT2AHPGD
SCHEMBL2730918 0.85 GAA (0.48) RECQLALDH1A1GAAMAPTMEN1
SCHEMBL2730661 0.84 GAA (0.47) RECQLALDH1A1GAAMAPTMEN1
SCHEMBL2731589 0.81 FOLH1 (0.46) ALDH1A1MEN1KMT2AL3MBTL1KDM4E
SCHEMBL12279719 0.77 HPGD (0.65) RECQLALDH1A1GAAMAPTMEN1
SCHEMBL2455488 0.76 ELANE (0.53) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL2887731 0.75 MAPT (0.64) RECQLALDH1A1GAAMAPTMEN1
SCHEMBL2730493 0.74 MAPK8 (0.42) ALDH1A1GAAMAPTKMT2ANPC1
SCHEMBL2730492 0.74 MAPK8 (0.42) ALDH1A1GAAMAPTKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635567-B1 INDOLE DERIVATIVES RICHTER GEDEON NYRT (HU) 2015-10-28 — — EP disclosed
EP-2635567-A1 INDOLE DERIVATIVES Richter Gedeon Nyrt. (HU) 2013-09-11 — — EP disclosed
US-20130217702-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. 2013-08-22 — — US disclosed
WO-2012059776-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217702-A1 INDOLE DERIVATIVES BDKRB1, BDKRB2, ARRB1 RECQL 1114/4885ALDH1A1 1752/4885GAA 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback